Denis Migliorini

9PUBLICATIONS
95CO-AUTHORS
Energy generation, conversion and storage (excl. chemical and electrical)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 25, 2026
MYCT1-IFITM2/3 interaction links endothelial endolysosomal trafficking to white adipose tissue expansion.

Laureline Wetterwald, Anna Köck, Tania Wyss

|Oct 22, 2025
Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.

Yannik Kaiser, Christopher S Garris, Eliana Marinari

|Oct 15, 2025
Dendritic cell progenitors engineered to express extracellular-vesicle-internalizing receptors enhance cancer immunotherapy in mouse models.

Ali Ghasemi, Amaia Martinez-Usatorre, Yang Liu

|May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure.

Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra

|Sep 13, 2024
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma.

Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture

|Jul 23, 2024
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors.

Rémi Vernet, Eugenio Fernandez, Denis Migliorini

Pageof 2

Frequent Collaborators

2 joint publications

Michele De Palma

2 joint publications

Valérie Dutoit

2 joint publications

Darel Martinez Bedoya

2 joint publications

Amaia Martinez-Usatorre